Position in NVO
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$2,764,699
+$472,639 QoQ
Shares Held
57,670
-7.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.06%
of 13F equity value
Holder Rank
#313
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Atwater Malick LLC holds $12,919,723 across 8 Drug Manufacturers - General names. NVO ranks #2 (21.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
27,778 | $7,054,778 | |
| 2 | NVO |
Novo Nordisk A S
This page
|
57,670 | $2,764,699 | |
| 3 | LLY |
ELI LILLY & Co
|
1,015 | $1,217,421 | |
| 4 | ABBV |
AbbVie Inc.
|
3,342 | $840,980 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,527 | $324,719 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,245 | $283,633 | |
| 7 | AMGN |
Amgen Inc
|
644 | $233,205 | |
| 8 | NVS |
Novartis AG
|
1,278 | $200,288 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,764,699 | 57,670 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $2,292,060 | 62,369 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $3,301,399 | 64,886 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $3,964,594 | 71,447 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $11,430,057 | 165,605 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $11,379,063 | 163,869 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $13,954,852 | 162,228 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $19,864,686 | 166,832 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $24,051,690 | 168,500 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $21,653,889 | 168,644 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $17,615,259 | 170,278 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $15,695,516 | 172,592 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $14,188,607 | 87,676 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $13,947,188 | 87,641 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $12,082,613 | 89,276 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $8,921,368 | 89,545 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $9,900,221 | 88,847 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $9,788,169 | 88,142 | Shares | Sole | 2022-04-08 | |
| 2021-12-31 | $9,598,176 | 85,698 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $8,307,169 | 86,524 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $7,158,732 | 85,457 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $5,494,797 | 81,501 | Shares | Sole | 2021-05-21 | |
| 2020-12-31 | $5,946,260 | 85,129 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $5,814,623 | 83,748 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $5,371,389 | 82,031 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $4,857,899 | 80,696 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||